Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Falling Comet
1665.1000 17.50 (1.06%)
NSE Jun 20, 2025 15:55 PM
Volume: 2.6M
 

logo
Sun Pharmaceutical Industries Ltd.
01 Feb 2025
1665.10
1.06%
buy
by BOB Capital Markets Ltd.
Target: 2086 | Upside : 25.3%
BOB Capital Markets Ltd.
Domestic sales grew by 14% in Q3FY25 driven partially by volume/new launches and price hikes. Strong domestic sales growth to continue
 
Sun Pharmaceutical I.. has an average target of 2088.00 from 8 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended
Market closes higher, Hindustan Aeronautics bags an order worth Rs 500 crore from ISRO
Trendlyne Marketwatch | 20 Jun 2025, 03:59PM
Winners and losers of 2025 in global indices | Screener: Nifty outperformers (so far) this year
The Baseline | 19 Jun 2025, 11:24AM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022